| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.0M | — |
| SG&A Expense | $23.0M | +403.5% |
| Operating Income | -$65.1M | -1323.6% |
| Pre-tax Income | -$64.5M | — |
| Income Tax | $36K | — |
| Net Income | -$50.0M | -1000.1% |
| EPS (Basic) | -$1.70 | — |
| EPS (Diluted) | -$1.70 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.5M | +5824.7% |
| Current Assets | $76.5M | +9539.8% |
| Total Assets | $76.8M | -33.7% |
| Current Liabilities | $7.7M | +98.1% |
| Total Liabilities | $8.1M | +2.3% |
| Stockholders' Equity | $48.9M | +792.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.9M | -9046.9% |
| Capital Expenditures | $16K | — |
| Investing Cash Flow | -$32.3M | — |
| Financing Cash Flow | $119.7M | — |
| Free Cash Flow | -$55.9M | — |